Loading clinical trials...
Loading clinical trials...
Prospective, Single-Center, Open-Label Study to Evaluate the Efficacy of the Alma Hybrid System for New Approach of Facial Skin Treatment With Minimal Downtime
Conditions
Interventions
Facial skin treatment
Locations
1
United States
Dermatology Associates of Plymouth Meeting, P.C.
Plymouth Meeting, Pennsylvania, United States
Start Date
November 25, 2020
Primary Completion Date
July 18, 2021
Completion Date
July 18, 2021
Last Updated
July 22, 2021
NCT07296536
NCT07261748
NCT06641869
NCT02910492
NCT02726451
NCT02551562
Lead Sponsor
Alma Lasers
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions